Pneumococcal Vaccines Market Share

Statistics for the 2023 & 2024 Pneumococcal Vaccines market share, created by Mordor Intelligence™ Industry Reports. Pneumococcal Vaccines share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Market Share of Pneumococcal Vaccines Industry

The pneumococcal vaccine market is highly consolidated and consists of a few players. Market players adopt various strategies to expand their business, such as acquisitions, collaborations, and product launches. Companies expand their presence in other geographies by collaborating with distributors and thus increase product availability, boosting market growth. Some companies currently dominating the market are GSK PLC, Pfizer Inc., CSL Ltd, Merck KGaA, Serum Institute of India Pvt. Ltd, and Sanofi.

Pneumococcal Vaccines Market Leaders

  1. Pfizer Inc.

  2. CSL Ltd.

  3. Serum Institute of India Pvt. Ltd.

  4. GSK plc

  5. Merck KGaA

*Disclaimer: Major Players sorted in no particular order

Pneumococcal Vaccines Market Concentration

Pneumococcal Vaccine Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)